- Upstream Ag Insights
- Posts
- Inside Miraterra’s Unique Bet on Soil Intelligence
Inside Miraterra’s Unique Bet on Soil Intelligence
A look at Miraterra technology along with its recent acquisition of Trace Genomics assets.
Index:
Overview
Trace Genomics Challenges
Economics and Change
Shopify-ication of Agriculture Service Providers
A look at Miraterra
Final Thoughts
Overview
Miraterra, a technology company known for unlocking measurement and insight across soil, plants, and food through breakthroughs in Raman spectroscopy, has acquired the assets of Trace Genomics Inc., including the full suite of Intellectual Property (IP), in-market products, and an analytical lab in Ames, Iowa.
This strategic acquisition combines forces of two leading technology platforms to rapidly advance the field of soil-to-table measurement and insights — supporting agriculture and advancing the resilience and restoration of our global soil health.
There are two notable angles with this news:
A look at the challenges for Trace Genomics
A look at Miraterra, current capabilities and acquisition rationale
Trace Genomics Challenges
Trace Genomics was a soil testing company that provided soil microbiome analysis using genomics. Their core offering was a soil test that looked at microbes, pathogens, and other soil indicators, delivering information to farmers and agronomists for making fertility and crop protection decisions. Trace also had a well built customer facing software to look at testing data.
There had been ongoing conversations within the industry about the financial challenges of Trace Genomics. The acquisition price was not disclosed, but we can gauge from founder and CEO of Trace Genomics, Poornima Parameswaran’s Linkedin post that the sale was not optimal— anytime a start-up sells to another one, it’s a sign of challenges.
In March I wrote What the Fall of 23andMe Could Signal for Soil Genomics Companies in Agriculture, but I have previously stated my bullishness for companies like Trace Genomics— from an agronomic perspective, I love the concept.
A deeper understanding of the soil, particularly surrounding biological parameters and fungal/bacterial pests has upside for agronomic decision making:

However, the question I poorly considered initially was: “At what cost?”
Economics and Change
Start-up soil testing companies have challenging economics, something I broke down early last year after Trace announced a Series B raise.
With any soil lab business, there are high fixed costs.
Even more when adding the genomics testing capabilities on top, which means they become a through-put business. Large volumes are required to spread out the high fixed costs.
But getting the volumes up at a manageable customer acquisition cost is difficult, making the unit economics a hurdle.

Subscribe to Upstream Ag Professional to read the rest.
Become a paying member of Upstream Ag to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In.
A professional subscription gets you:
- • Subscriber-only insights and deep analysis plus full archive access
- • Audio edition for consumption flexibility
- • Access to industry reports, the Visualization Hub and search functionality